MX2017009193A - Lente de contacto iontoforetica. - Google Patents

Lente de contacto iontoforetica.

Info

Publication number
MX2017009193A
MX2017009193A MX2017009193A MX2017009193A MX2017009193A MX 2017009193 A MX2017009193 A MX 2017009193A MX 2017009193 A MX2017009193 A MX 2017009193A MX 2017009193 A MX2017009193 A MX 2017009193A MX 2017009193 A MX2017009193 A MX 2017009193A
Authority
MX
Mexico
Prior art keywords
charged
therapeutic composition
charged therapeutic
current source
compound
Prior art date
Application number
MX2017009193A
Other languages
English (en)
Inventor
Manzo Michael
Original Assignee
Eyegate Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyegate Pharmaceuticals Inc filed Critical Eyegate Pharmaceuticals Inc
Publication of MX2017009193A publication Critical patent/MX2017009193A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Neurology (AREA)

Abstract

Se proveen lentes de contacto para terapia iontoforética ocular, cuyas implementaciones incluyen un depósito adaptado para contener un compuesto terapéutico cargado, una fuente de corriente que provee corriente iontoforética a la composición terapéutica cargada que afecta el suministro de la composición terapéutica cargada en un globo ocular, y un circuito de detección que controla la fuente de corriente para mantener una escala de pH seleccionada de la composición terapéutica cargada; modalidades alternativas incluyen electrodos de sacrificio activos para generar iones suficientes para proveer una fuerza repulsiva electromotriz al compuesto cargado para efectuar el transporte en el tejido ocular.
MX2017009193A 2015-01-22 2016-01-22 Lente de contacto iontoforetica. MX2017009193A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562106578P 2015-01-22 2015-01-22
PCT/US2016/014636 WO2016118933A1 (en) 2015-01-22 2016-01-22 Iontophoretic contact lens

Publications (1)

Publication Number Publication Date
MX2017009193A true MX2017009193A (es) 2017-12-12

Family

ID=56417852

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009193A MX2017009193A (es) 2015-01-22 2016-01-22 Lente de contacto iontoforetica.

Country Status (9)

Country Link
US (1) US9937074B2 (es)
EP (1) EP3247452A4 (es)
JP (1) JP2018502639A (es)
CN (1) CN106999711A (es)
AU (1) AU2016209028A1 (es)
BR (1) BR112017009054A2 (es)
CA (1) CA2973595A1 (es)
MX (1) MX2017009193A (es)
WO (1) WO2016118933A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11787783B2 (en) 2016-12-13 2023-10-17 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
MX2019006863A (es) 2016-12-13 2019-09-13 Beta Therapeutics Pty Ltd Inhibidores de heparanasa y uso de los mismos.
DE102017213056A1 (de) 2017-07-28 2019-01-31 Continental Teves Ag & Co. Ohg Verfahren zum Unterdrücken von Bremsgeräuschen, zentraler Server, Fahrzeugsteuerungsmodul und Speichermedium
WO2020028829A1 (en) * 2018-08-02 2020-02-06 University Of Florida Research Foundation Methods and compositions for iontophoretic drug delivery to the eye
WO2020072513A1 (en) * 2018-10-02 2020-04-09 Tufts Medical Center, Inc. Systems and methods for sensing and correcting electrical activity of nerve tissue
KR102137437B1 (ko) 2018-11-06 2020-07-24 한국과학기술연구원 비침습적 약물 전달용 스마트 콘택트렌즈
EP3909056B1 (en) 2019-01-09 2025-05-21 Verily Life Sciences LLC Programmable therapeutic agent delivery from eye mounted device
WO2020146362A1 (en) 2019-01-09 2020-07-16 Verily Life Sciences Llc Eye mounted device for therapeutic agent release
EP3936091B1 (en) * 2019-03-04 2023-07-19 Tohoku University Method for absorbing or discharging water in ophthalmic medical device and ophthalmic medical device
EP3946185A4 (en) * 2019-04-02 2022-11-30 The Regents of the University of California METHOD AND DEVICE FOR ALTERING THE CORNEA BY MEANS OF ELECTROCHEMISTRY
CN110367927B (zh) * 2019-08-01 2022-04-08 中山大学 青光眼眼压连续检测系统及其检测方法
WO2022026720A1 (en) * 2020-07-31 2022-02-03 Board Of Regents Of The University Of Nebraska Hydrogel ionic circuit based devices for electrical stimulation and drug therapy
CN114355628A (zh) * 2020-09-29 2022-04-15 鼎硕光学股份有限公司 光学装置及其制造方法
CN113413541A (zh) * 2021-06-17 2021-09-21 中央民族大学 一种利用环状电极的眼部离子电渗透药物输送设备及方法
WO2023076141A1 (en) * 2021-10-28 2023-05-04 Twenty Twenty Therapeutics Llc Controlled release of a therapeutic from an ophthalmic device with a locally enhanced concentration of chloride ions
CN117281683B (zh) * 2023-09-21 2026-06-30 中山火炬职业技术学院 一种离子电渗凝胶巩膜接触镜及其制备方法
WO2025096506A1 (en) * 2023-11-03 2025-05-08 Verily Life Sciences Llc Ophthalmic device with a shielding material to protect against degradation during active drug release

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US6544193B2 (en) 1996-09-04 2003-04-08 Marcio Marc Abreu Noninvasive measurement of chemical substances
FR2773320B1 (fr) * 1998-01-05 2000-03-03 Optisinvest Dispositif pour le transfert intraoculaire de produits actifs par iontophorese
US7346389B1 (en) * 1998-09-24 2008-03-18 Newsome David A Dilation enhancer with pre-medicated contact lenses
EP1171195B1 (en) * 1999-04-16 2005-03-16 Johnson & Johnson Consumer Companies, Inc. Electrotransport delivery system comprising internal sensors
US6319240B1 (en) 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
US6539251B2 (en) 1999-05-25 2003-03-25 Iomed, Inc. Ocular iontophoretic apparatus
US6579276B2 (en) 2001-01-22 2003-06-17 Iomed, Inc. Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the same
US6697668B2 (en) 2001-01-25 2004-02-24 Iomed, Inc. Ocular iontophoretic device and method for using the same
US20020107508A1 (en) 2001-02-05 2002-08-08 Burnett Daniel R. Incisionless corneal sculpting technique and devices
FR2830767B1 (fr) 2001-10-12 2004-03-12 Optis France Sa Dispositif de delivrance de medicaments par iontophorese ou electroporation introculaire
FR2830766B1 (fr) 2001-10-12 2004-03-12 Optis France Sa Dispositif de delivrance de medicaments par iontophorese transpalpebrale
IL161529A0 (en) 2001-10-31 2004-09-27 R & R Ventures Inc Iontophoresis device
IL147921A0 (en) 2002-01-31 2002-08-14 Abdulrazik Mohammad A method for treating central nervous system disorders by ocular dosing
US6801804B2 (en) 2002-05-03 2004-10-05 Aciont, Inc. Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
AU2005247122C1 (en) 2004-04-30 2012-02-02 Eyegate Pharma S.A. Irritation-reducing ocular iontophoretic device
FR2869531B1 (fr) 2004-04-30 2006-07-14 Optis France Sa Sa Dispositif de iontophorese oculaire diminuant les irritations
US20060089590A1 (en) * 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
WO2006072887A1 (en) 2005-01-05 2006-07-13 Eyegate Pharma Sa Ocular iontophoresis device for delivering sirna and aptamers
US20100028406A1 (en) 2005-08-05 2010-02-04 Universite De Geneve Topical drug delivery by iontophoresis
US8755880B2 (en) 2005-10-24 2014-06-17 Aciont, Inc. Intraocular iontophoretic device and associated methods
US20070260171A1 (en) * 2005-09-27 2007-11-08 Higuchi John W Intraocular iontophoretic device and associated methods
EP1928542A1 (en) * 2005-09-30 2008-06-11 Tti Ellebeau, Inc. Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
WO2007038555A1 (en) 2005-09-30 2007-04-05 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
US8634907B2 (en) * 2005-10-24 2014-01-21 Aciont, Inc. Intraocular iontophoretic device and associated methods
US8099162B2 (en) 2005-11-29 2012-01-17 Eyegate Pharma, S.A.S. Ocular iontophoresis device
US20070299386A1 (en) 2006-06-23 2007-12-27 Minu, L.L.C. Delivery of an ocular agent using iontophoresis
WO2008013913A2 (en) 2006-07-26 2008-01-31 Aciont, Inc. Method and device for minimally invasive site specific ocular drug delivery
WO2008125908A2 (en) 2006-12-05 2008-10-23 Eyegate Pharma S.A. Enhanced retinal delivery of a nucleic acid through iontophoresis
CN104473966A (zh) 2007-09-28 2015-04-01 强生消费者公司 产生电流的颗粒及其用途
US8480638B2 (en) * 2007-10-04 2013-07-09 Aciont, Inc. Intraocular iontophoretic device and associated methods
CA2716390C (en) 2008-02-25 2016-08-23 Eyegate Pharma S.A.S. Enhanced delivery of a therapeutic to ocular tissues through iontophoresis
US20100040669A1 (en) 2008-08-12 2010-02-18 Higuchi John W Non-Invasive Ocular Delivery of Rapamycin
JP5723293B2 (ja) * 2008-12-31 2015-05-27 アイゲート・ファーマシューティカルズ・インコーポレーテッドＥｙｅｇａｔｅ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 緩衝系を用いた経眼イオントフォレシスの装置および方法
WO2012095876A1 (en) 2011-01-12 2012-07-19 Sooft Italia Spa Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus
WO2012162459A1 (en) 2011-05-26 2012-11-29 Pepose Jay Device and method for administering eye medications
US8857983B2 (en) 2012-01-26 2014-10-14 Johnson & Johnson Vision Care, Inc. Ophthalmic lens assembly having an integrated antenna structure
US20140107025A1 (en) 2012-04-16 2014-04-17 Jade Therapeutics, Llc Ocular drug delivery system
WO2014004845A1 (en) * 2012-06-29 2014-01-03 Johnson & Johnson Vision Care, Inc. Method and ophthalmic device for galvanic healing of an eye
US20140190839A1 (en) 2012-08-06 2014-07-10 Google Inc. Contact lenses having two-electrode electrochemical sensors
US8971978B2 (en) 2012-08-21 2015-03-03 Google Inc. Contact lens with integrated pulse oximeter
US8960899B2 (en) 2012-09-26 2015-02-24 Google Inc. Assembling thin silicon chips on a contact lens
US20150305929A1 (en) 2012-11-07 2015-10-29 Emmetrope Ophthalmics Llc Magnetic contact lenses and methods of treatment and diagnosis using the same
CN203389001U (zh) 2013-05-30 2014-01-15 中山大学中山眼科中心 一种眼后段透巩膜控释给药装置
US9101309B1 (en) 2013-11-26 2015-08-11 Google Inc. Method and system for measuring retinal
US9289123B2 (en) 2013-12-16 2016-03-22 Verily Life Sciences Llc Contact lens for measuring intraocular pressure
US9761874B2 (en) 2013-12-30 2017-09-12 Verily Life Sciences Llc Fabrication methods for batteries
US9678361B2 (en) 2014-06-13 2017-06-13 Verily Life Sciences Llc Power delivery for accommodation by an eye-mountable device

Also Published As

Publication number Publication date
JP2018502639A (ja) 2018-02-01
CA2973595A1 (en) 2016-07-28
WO2016118933A1 (en) 2016-07-28
EP3247452A4 (en) 2018-11-14
EP3247452A1 (en) 2017-11-29
AU2016209028A1 (en) 2017-05-11
CN106999711A (zh) 2017-08-01
BR112017009054A2 (pt) 2018-01-30
US9937074B2 (en) 2018-04-10
US20160213514A1 (en) 2016-07-28

Similar Documents

Publication Publication Date Title
BR112017009054A2 (pt) lente de contato para terapia ocular.
MX2017005204A (es) Dispositivos y métodos de estimulación para tratar el ojo seco.
EP4552592A3 (en) Optimization of energy delivery for various applications
WO2019057511A3 (en) Electrical method of delivering hyaluronic acid through the skin
EP3872908A4 (en) Electrode pole piece and electrochemical device
EP4218910A3 (en) Cardiac pacing system
EA201590502A1 (ru) Система доставки глазного имплантата
NZ737871A (en) Electroporation system for controlled localized therapeutics delivery
EP3558446A4 (en) "INTELLIGENT" ELECTRODES SET FOR TRANSCUTANEOUS ELECTRIC NERVOUS STIMULATION (TENS)
SG11202103614RA (en) Generation of improved human pah for treatment of severe pku by liver-directed gene replacement therapy
EP4302736A3 (en) Ophthalmic implant for delivering therapeutic substances
PH12018500047B1 (en) Notch pathway signaling inhibitor compounds
WO2013042068A3 (en) Medical implant with current leakage circuitry
EP2593179A4 (en) DEPOSITION REMOVAL INSIDE AND OUTSIDE CIRCULATORY SYSTEMS
CA2869873C (en) Biomedical electrode
JP2018502639A5 (es)
PL4019885T3 (pl) Granat hukowo-błyskowy ze środkami do regulacji mocy czynnej
GB2541840A (en) Ophthalmic composition for the treatment of ocular infection
EA201490845A1 (ru) Улучшенная сшивающая композиция, доставляемая способом ионтофореза, пригодная для лечения кератоконуса
MX2010006019A (es) Metodos para administrar acido ribonucleico pequeño de interferencia (arnsi) mediante iontoforesis.
PH12019501785B1 (en) Intranasal composition comprising betahistine
WO2019112750A3 (en) Apparatus and methods for fluidic microactuation of electrodes
NZ590356A (en) Administration of the drug sumatriptan by iontophoresis
MX2018000287A (es) Dispositivo de electroestimulacion.
SG11202103952WA (en) Implantable electrode lead with active fixation